Immunoblot analysis of cell cycle proteins showed that, following 24/48 h treatment with BSHE (GR50), p21, a CDK inhibitor transcriptionally controlled by p53 that can induce G1 arrest, increased in all cell lines except for PC3 prostate cancer cells. The gene discussed is CDKN1A; the disease is prostate carcinoma.